0001213900-23-092691.txt : 20231204 0001213900-23-092691.hdr.sgml : 20231204 20231204161511 ACCESSION NUMBER: 0001213900-23-092691 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231130 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tenon Medical, Inc. CENTRAL INDEX KEY: 0001560293 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455574718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41364 FILM NUMBER: 231463208 BUSINESS ADDRESS: STREET 1: 104 COOPER CT. CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: (408) 649-5760 MAIL ADDRESS: STREET 1: 104 COOPER CT. CITY: LOS GATOS STATE: CA ZIP: 95032 8-K 1 ea189482-8k_tenonmed.htm CURRENT REPORT
0001560293 false 0001560293 2023-11-30 2023-11-30 0001560293 TNON:CommonStockParValue0.001PerShareMember 2023-11-30 2023-11-30 0001560293 TNON:WarrantsMember 2023-11-30 2023-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):

November 30, 2023

 

TENON MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41364   45-5574718
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

104 Cooper Court    
Los Gatos, CA   95032
(Address of principal executive offices)   (Zip Code)

 

(408) 649-5760

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   TNON   The Nasdaq Stock Market LLC
Warrants   TNONW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

  

(b) Resignation of Board Member

 

On November 30, 2023, Frank Fischer informed Tenon Medical, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (“Board”), which was immediately effective. Mr. Fischer served as a member of the Board’s Audit Committee and Chairman of the Compensation Committee.  Mr. Fischer’s resignation as a director is due to a recently occurring conflict of interest and not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 4, 2023 TENON MEDICAL, INC.
     
  By: /s/ Steven M. Foster
  Name: Steven M. Foster
  Title: Chief Executive Officer and President

 

 

2

 

 

EX-101.SCH 2 tnon-20231130.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 tnon-20231130_def.xml XBRL DEFINITION FILE EX-101.LAB 4 tnon-20231130_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 tnon-20231130_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 30, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 30, 2023
Entity File Number 001-41364
Entity Registrant Name TENON MEDICAL, INC.
Entity Central Index Key 0001560293
Entity Tax Identification Number 45-5574718
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 104 Cooper Court
Entity Address, City or Town Los Gatos
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95032
City Area Code (408)
Local Phone Number 649-5760
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.001 per share  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol TNON
Security Exchange Name NASDAQ
Warrants  
Title of 12(b) Security Warrants
Trading Symbol TNONW
Security Exchange Name NASDAQ
XML 7 ea189482-8k_tenonmed_htm.xml IDEA: XBRL DOCUMENT 0001560293 2023-11-30 2023-11-30 0001560293 TNON:CommonStockParValue0.001PerShareMember 2023-11-30 2023-11-30 0001560293 TNON:WarrantsMember 2023-11-30 2023-11-30 iso4217:USD shares iso4217:USD shares 0001560293 false 8-K 2023-11-30 TENON MEDICAL, INC. DE 001-41364 45-5574718 104 Cooper Court Los Gatos CA 95032 (408) 649-5760 false false false false Common Stock, par value $0.001 per share TNON NASDAQ Warrants TNONW NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

JQ"(6,P$ "(" M / " :L0 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 M" #D@817)!Z;HJT #X 0 &@ @ $+$@ >&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #D@81799!YDAD! #/ P M$P @ 'P$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .."0 ) #X" Z% ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://tenonmed.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea189482-8k_tenonmed.htm tnon-20231130.xsd tnon-20231130_def.xml tnon-20231130_lab.xml tnon-20231130_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea189482-8k_tenonmed.htm": { "nsprefix": "TNON", "nsuri": "http://tenonmed.com/20231130", "dts": { "inline": { "local": [ "ea189482-8k_tenonmed.htm" ] }, "schema": { "local": [ "tnon-20231130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "tnon-20231130_def.xml" ] }, "labelLink": { "local": [ "tnon-20231130_lab.xml" ] }, "presentationLink": { "local": [ "tnon-20231130_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://tenonmed.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea189482-8k_tenonmed.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea189482-8k_tenonmed.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://tenonmed.com/role/Cover" ], "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "TNON_CommonStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://tenonmed.com/20231130", "localname": "CommonStockParValue0.001PerShareMember", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "TNON_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://tenonmed.com/20231130", "localname": "WarrantsMember", "presentation": [ "http://tenonmed.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001213900-23-092691-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-092691-xbrl.zip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